Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study

Fig. 4

Cumulative ESRD-free survival in MPA and GPA patients and among the four EUVAS-defined disease severity types. a ESRD-free survival rates in MPA and GPA patients. b ESRD-free survival rates among patients with the four types of EUVAS disease severity. Cumulative ESRD-free survival rates at 24 months are shown at the end of the survival curve for each group. ESRD end-stage renal disease, GPA granulomatosis with polyangiitis, MPA microscopic polyangiitis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us